Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $61 to $66.
Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $61 to $66.